Literature DB >> 8727889

Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.

E Mahenthiralingam1, M E Campbell, J Foster, J S Lam, D P Speert.   

Abstract

Pseudomonas aeruginosa isolates recovered from chronically colonized patients with cystic fibrosis (CF) are phenotypically different from those collected from other patients or from the environment. To assess whether alterations in motility, mucoidy, and serum susceptibility represented an adaptation to chronic infection or replacement by a new strain, sequential P. aeruginosa isolates of known phenotype collected from 20 CF patients were typed by random amplified polymorphic DNA (RAPD) analysis. A total of 35 RAPD strain types were found among 385 isolates from 20 patients, and only two patients had P. aeruginosa strains of the same RAPD fingerprint. Eight strain pairs representative of the first eight RAPD types were also analyzed by SpeI macrorestriction followed by pulsed-field gel electrophoresis (PFGE); the strain types found by both fingerprinting techniques correlated exactly. In 11 of 20 patients, the RAPD types of serial P. aeruginosa isolates remained stable despite alterations in isolate motility, colonial morphology, and lipopolysaccharide phenotype. However, in isolates collected from one CF patient, a single band change in RAPD fingerprint and CeuI PFGE profile correlated with the appearance of an RpoN mutant phenotype, suggesting that the altered phenotype may have been due to a stable genomic rearrangement. Secretion of mucoid exopolysaccharide, loss of expression of RpoN-dependent surface factors, and acquisition of a serum-susceptible phenotype in P. aeruginosa appear to evolve during chronic colonization in CF patients from specific adaptation to infection rather than from acquisition of new bacterial strains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8727889      PMCID: PMC228968          DOI: 10.1128/jcm.34.5.1129-1135.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.

Authors:  J G Williams; A R Kubelik; K J Livak; J A Rafalski; S V Tingey
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

2.  Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.

Authors:  D P Speert; M E Campbell; S W Farmer; K Volpel; A M Joffe; W Paranchych
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

3.  The rpoN gene product of Pseudomonas aeruginosa is required for expression of diverse genes, including the flagellin gene.

Authors:  P A Totten; J C Lara; S Lory
Journal:  J Bacteriol       Date:  1990-01       Impact factor: 3.490

4.  Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre.

Authors:  N Høiby; K Rosendal
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-06

5.  Comparison of arbitrarily primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients.

Authors:  D Kersulyte; M J Struelens; A Deplano; D E Berg
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

6.  Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis.

Authors:  D P Speert; M E Campbell
Journal:  J Hosp Infect       Date:  1987-01       Impact factor: 3.926

7.  Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.

Authors:  C Wolz; G Kiosz; J W Ogle; M L Vasil; U Schaad; K Botzenhart; G Döring
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

8.  In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement.

Authors:  D E Woods; P A Sokol; L E Bryan; D G Storey; S J Mattingly; H J Vogel; H Ceri
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

9.  The effect of piliation and exoproduct expression on the adherence of Pseudomonas aeruginosa to respiratory epithelial monolayers.

Authors:  L Saiman; K Ishimoto; S Lory; A Prince
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

10.  Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa.

Authors:  J W Ogle; J M Janda; D E Woods; M L Vasil
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 7.759

View more
  123 in total

1.  Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors:  D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa.

Authors:  M Campbell; E Mahenthiralingam; D P Speert
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Stability of repetitive-sequence PCR patterns with respect to culture age and subculture frequency.

Authors:  Hyunseok Peter Kang; W Michael Dunne
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

4.  Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics.

Authors:  David Armstrong; Scott Bell; Michael Robinson; Peter Bye; Barbara Rose; Colin Harbour; Crystal Lee; Helen Service; Michael Nissen; Melanie Syrmis; Claire Wainwright
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

5.  O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa.

Authors:  Karine Faure; David Shimabukuro; Temitayo Ajayi; Leonard R Allmond; Teiji Sawa; Jeanine P Wiener-Kronish
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

6.  V-antigen genotype and phenotype analyses of clinical isolates of Pseudomonas aeruginosa.

Authors:  Leonard R Allmond; Temitayo Ajayi; Kiyoshi Moriyama; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

7.  Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.

Authors:  Catherine Llanes; Didier Hocquet; Christelle Vogne; Dounia Benali-Baitich; Catherine Neuwirth; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 8.  Advances in electronic-nose technologies developed for biomedical applications.

Authors:  Alphus D Wilson; Manuela Baietto
Journal:  Sensors (Basel)       Date:  2011-01-19       Impact factor: 3.576

9.  A new highly discriminatory multiplex capillary-based MLVA assay as a tool for the epidemiological survey of Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  D Sobral; P Mariani-Kurkdjian; E Bingen; H Vu-Thien; K Hormigos; B Lebeau; F Loisy-Hamon; A Munck; G Vergnaud; C Pourcel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-11       Impact factor: 3.267

10.  Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity.

Authors:  Nathan E Head; Hongwei Yu
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.